Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancerMarina Elena Cazzaniga, Maureen Trudeau, Thierry Petit et al.|JNCI Cancer Spectrum|2023Cited by 3